Dafna Capital Trims IShares ETF: Biotech Portfolio Moves
A major move by a prominent asset manager reveals how large portfolios tweak biotech bets. Learn what the trim means ...
Which Credit Card Has The Best Cash Back Offer
Discover which credit card has the best cash back offer available, ensuring you get the most value from your spending.
28,369 articlesQualcomm Just Nearly Doubled: A Bold AI Growth Plan
Qualcomm just outlined a much larger growth plan, signaling a strong bet on AI beyond smartphones. This deep dive exp...
Prediction: Tesla Stock Could Go Parabolic After July 2
As Tesla faces mixed results and macro headwinds, a potential post-July 2 rally lures investors. This guide breaks do...
Inflation Slowed June: These Signals Hint Hikes May Follow
June inflation slowed, but the path for interest rates is far from clear. This piece unpacks these four words, explai...
U.S. Housing Starting Crash? A Pragmatic Investor Guide
The mood around U.S. housing is shifting. Prices, rents, and mortgage costs are moving in ways that could change how ...
Peter Thiel Warned Coming: Banks Embrace AI-Driven Cuts
A wave of AI-driven efficiency moves is prompting banks to trim payrolls. The trend rekindles a widely circulated war...
CrowdStrike Climbs 11%, Palo Rises as Cyber Stocks Rally
Cybersecurity shares jumped after inflation data cooled, lifting risk sentiment. CrowdStrike climbs 11% and Palo Alto...
AT&T Dismisses Starlink Threat, Stays Focused on Fiber
AT&T tells CNBC that Starlink faces a late-arrival risk, citing a fiber-first moat and evolving wireless growth. The ...
JEPI’s Covered-Call Strategy Could Deliver Consistent Income
A steady-income approach from JEPI tests traditional retirement cash flow models as market volatility shapes option p...
Allogene (ALLO) 2026 Earnings Outlook for Investors
This guide breaks down what to watch in allogene (allo) 2026 earnings. Learn how pipeline progress, cash runway, and ...
Coca-Cola vs Exxon: Which Blue Chip Won the Decade?
As 2025 winds down, Coca-Cola and Exxon Mobil stand as twin blue chips with very different stories. One fuels steady ...
Lilly's $3.8 Billion Vaccine Bets: A Quiet Shift Now
Lilly's heavy reliance on GLP-1 drugs has investors watching as the company bets $3.8B on vaccines. This analysis exp...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status